IR Biosciences Holdings, Inc.
IRBS
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -- | -- | -91.12% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -27.70% | -93.35% | -88.55% | -78.46% | -70.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -93.79% | -68.35% | -47.06% |
| Total Current Assets | -87.12% | -99.45% | -98.87% | -98.28% | -89.68% |
|
|
|||||
| Total Current Assets | -87.12% | -99.45% | -98.87% | -98.28% | -89.68% |
| Net Property, Plant & Equipment | -28.42% | -28.84% | -29.83% | -28.34% | -29.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 4.05% | 4.05% |
| Total Assets | -82.93% | -96.97% | -97.43% | -96.90% | -88.76% |
|
|
|||||
| Total Accounts Payable | 206.76% | 174.62% | 116.11% | 55.66% | -7.42% |
| Total Accrued Expenses | 7,115.63% | 3,318.75% | -71.68% | -71.68% | 0.00% |
| Short-term Debt | 96.44% | 237.85% | 89.18% | -45.60% | -37.97% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 80.70% | -- | 100.00% | 33.33% | 33.33% |
| Total Finance Division Other Current Liabilities | 0.00% | 32.87% | 216.64% | 287.72% | 9,375.00% |
| Total Other Current Liabilities | 0.00% | 32.87% | 216.64% | 287.72% | 9,375.00% |
| Total Current Liabilities | 110.89% | -1.92% | 111.40% | 46.76% | 30.58% |
|
|
|||||
| Total Current Liabilities | 110.89% | -1.92% | 111.40% | 46.76% | 30.58% |
| Long-Term Debt | -- | -26.16% | -4.64% | 20.61% | -23.26% |
| Short-term Debt | 96.44% | 237.85% | 89.18% | -45.60% | -37.97% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -60.32% | -59.73% | -38.33% | 195.72% | -- |
| Total Liabilities | -21.29% | -33.60% | 19.34% | 63.91% | 22.82% |
|
|
|||||
| Common Stock & APIC | 5.34% | 5.70% | 6.30% | 2.77% | -6.71% |
| Retained Earnings | -19.01% | -14.75% | -17.43% | -32.63% | -13.05% |
| Treasury Stock & Other | -- | -- | -- | -- | -95.92% |
| Total Common Equity | -47.56% | -31.88% | -47.62% | -143.29% | -113.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -47.56% | -31.88% | -47.62% | -143.29% | -113.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.65% | 27.79% | -47.62% | -143.29% | -113.31% |
|
|
|||||